Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Sagent Pharmaceuticals and Qilu Pharmaceutical sign $4.5bn injectable drug deal to boost U.S. hospital supply access Sagent Pharmaceuticals signs $4.5B deal with Qilu Pharmaceutical to boost U.S. access to complex injectable drugs, improving affordability and supply resilience. byPallavi MadhirajuJuly 8, 2025